Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease

  • Mehdi Namdar,
  • Catherine Gebhard,
  • Rafael Studiger,
  • Yi Shi,
  • Pavani Mocharla,
  • Christian Schmied,
  • Pedro Brugada,
  • Thomas F. Lüscher,
  • Giovanni G. Camici

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease

  • Mehdi Namdar, 
  • Catherine Gebhard, 
  • Rafael Studiger, 
  • Yi Shi, 
  • Pavani Mocharla, 
  • Christian Schmied, 
  • Pedro Brugada, 
  • Thomas F. Lüscher, 
  • Giovanni G. Camici
PLOS
x

In our experiments, we used GlobotriaosylCERAMIDE (Gb3) and not - as wrongly stated - GlobotriaosylSPHINGOSINE (lyso-Gb3). Nevertheless, the abbreviation we used, "Gb3", is the correct one and accurate throughout the manuscript. The instances in the text where the substance's name is mentioned in full should be corrected; more precisely the title, the abstract (background section) and the Introduction section (3rd line). In those three cases, Globotriaosylsphingosine should be replaced by Globotriaosylceramide. The correct citation is: Namdar M, Gebhard C, Studiger R, Shi Y, Mocharla P, et al. (2012) Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease. PLoS ONE 7(4): e36373. doi:10.1371/journal.pone.0036373